Your search matched 49 results
How COVID-19 and 3 other barriers will transform healthcare over the next few years.
At a time when most clinicians are overwhelmed and overworked, Microsoft and GE Healthcare are partnering together to help ease the burden of patient monitoring with a new cloud-based tool.
The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.
Achieving success in the current global context now hinges on “the virtual meeting” – the most important method for teams to stay connected, troubleshoot, and drive results.
Is Your Mask Up to the Task? | Blog
Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.
Virtual delivery requires you to rethink your content and approaches.
COVID-19: Optimizing Promotions with HCP Preferences | Perspectives
Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.
Recommendations for activities to inform and engage
COVID-19: How are Payers Managing These Days? | Perspectives
How are payers responding to COVID-19?
Meet Think Bank | Perspectives
Think Bank is an agile way to answer complex questions.
Leading Through Uncertainty Amidst the Global Pandemic | Perspectives
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.
To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.
MM&M eBook: Marketing in a Crisis | In The Media
In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."
Our Virtual Reality | Perspectives
Virtual collaboration isn’t the future of work – it's the wave of the present
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
Demonstrating Value in the Real World | Perspectives
Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.
It's Time for a Digital Reset | Perspectives
What should the evolution of your digital strategy look like through COVID-19 and beyond?
Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.
COVID-19 has accelerated the rate at which we’re seeing change happening around us.
Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.
As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.
At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.
Patients are often at risk when presented with mixed messages.
You might want to think twice about ignoring that call from a random number.
As the pandemic surged, New York City’s Mt.
Payer Priorities in a Pandemic | In The Media
What are payers focused on during the COVID-19 pandemic?
Ten years after acquiring its competitor Duane Reade, Walgreens has set its sights on a whole different type of growth, announcing its plan to establish doctor’s offices in hundreds of its familiar brick-and-mortar stores.
COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.